LOADING
Comparing Broadcom Inc (AVGO) and Merck & Company (MRK) across the Technology and Health Care sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | AVGO | MRK |
|---|---|---|
| Price | $422.76 | $111.90 |
| Change Today | +0.67% | -2.37% |
| Market Cap | $2.00T | $283.1B |
| P/E Ratio | 81.9 | 15.7 |
| Forward P/E | 37.7 | 22.4 |
| PEG Ratio | 0.91 | 3.50 |
| EPS | $5.16 | $7.28 |
| Revenue Growth (YoY) | 29.5% | 5.0% |
| Profit Margin | 36.6% | 28.1% |
| Return on Equity | 33.4% | 36.9% |
| Dividend Yield | 0.59% | 2.87% |
| Beta | 1.25 | 0.28 |
| 52-Week High | $429.31 | $124.22 |
| 52-Week Low | $182.54 | $70.74 |
| Volume | 22.5M | 7.1M |
Broadcom Inc is the larger company by market capitalization. Merck & Company trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Merck & Company offers a higher dividend yield for income investors. Broadcom Inc has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.